Sign In
Buy GMED
$77.95
-0.300 (-0.383%)
At Close: Jun 03, 2026
Globus Medical (GMED) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
10:21am, Wednesday, 14'th Feb 2024
Beyond analysts' top -and-bottom-line estimates for Globus Medical (GMED), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the
Globus Medical Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call
05:17pm, Tuesday, 13'th Feb 2024
AUDUBON, Pa., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full year
3 Medtech Stocks Likely to Top Estimates This Earnings Season
08:51am, Tuesday, 13'th Feb 2024
Here are three stocks, GMED, GKOS and PRCT, which are expected to beat earnings estimates in the ongoing reporting cycle.
Will Globus Medical (GMED) Beat Estimates Again in Its Next Earnings Report?
01:11pm, Wednesday, 24'th Jan 2024
Globus Medical (GMED) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Here's Why You Should Retain Globus Medical (GMED) Stock Now
09:46am, Tuesday, 23'rd Jan 2024
Investors continue to be optimistic about Globus Medical (GMED), backed by the NuVasive merger and its prominence in the musculoskeletal field.
7 Healthcare Stocks Taking Medicine to the Next Level
12:54pm, Sunday, 14'th Jan 2024
While the technology sector – especially regarding artificial intelligence – may have captured the spotlight, investors ought to consider adding healthcare stocks to their portfolio. If I had to b
Globus Medical (GMED) Gains From Innovation Amid Macro Issues
11:17am, Friday, 29'th Dec 2023
Globus Medical (GMED) is particularly seeing notable gains in expandables, biologics, MIS screws, 3D printed implants and cervical offerings.
Here's Why You Should Retain Globus Medical (GMED) Stock Now
01:32pm, Friday, 15'th Dec 2023
Investors are optimistic about Globus Medical (GMED) on growing demand for musculoskeletal devices and its strong solvency position.
3 Stocks at the Forefront of Medical Robotics
02:31pm, Sunday, 10'th Dec 2023
Every now and then, speculation – within carefully defined limits – may be appropriate, which brings us to the case for medical robotics stocks to buy. Sure, you can gamble on just about anything
Globus Medical: Merger Overhang Lingering
06:05pm, Monday, 27'th Nov 2023
Globus Medical, Inc., a mid-cap medical device company, has seen its stock decline by over 35% in 2023 due mainly to its merger with Nuvasive. While the combination gives Globus Medical an over 20% ma
Globus Medical (GMED) Q3 Earnings Top Estimates, Margins Down
09:01am, Wednesday, 08'th Nov 2023
Globus Medical's (GMED) legacy business continues to drive share growth across its U.S. spine and trauma portfolios in the third quarter.
Globus Medical, Inc. (GMED) Q3 2023 Earnings Call Transcript
10:01pm, Tuesday, 07'th Nov 2023
Globus Medical, Inc. (NYSE:GMED ) Q3 2023 Earnings Conference Call November 7, 2023 4:30 PM ET Company Participants Brian Kearns - SVP, Business Development & IR Daniel Scavilla - President, CEO & Dir
Globus Medical (GMED) Reports Q3 Earnings: What Key Metrics Have to Say
08:17pm, Tuesday, 07'th Nov 2023
While the top- and bottom-line numbers for Globus Medical (GMED) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metric
Why Globus Medical (GMED) is Poised to Beat Earnings Estimates Again
01:32pm, Monday, 06'th Nov 2023
Globus Medical (GMED) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Globus Medical Schedules Third Quarter Earnings Release and Conference Call
04:30pm, Tuesday, 24'th Oct 2023
AUDUBON, Pa., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the third quarter ended September
